References
- Malik AM, Tupchong S, Huang S, Are A, Hsu S, Motaparthi K. An Updated Review of Pemphigus Diseases. Medicina (Kaunas). 2021 Oct 9;57(10):1080.
- Pratasava V, Sahni VN, Suresh A et al. Bullous Pemphigoid and Other Pemphigoid Dermatoses. Medicina (Kaunas). 2021 Oct 4;57(10):1061.
- Ghodsi SZ, Chams-Davatchi C, Daneshpazhooh M, Valikhani M, Esmaili N. Quality of life and psychological status of patients with pemphigus vulgaris using Dermatology Life Quality Index and General Health Questionnaires. J Dermatol. 2012 Feb;39(2):141-4.
- Kouris A, Platsidaki E, Christodoulou C et al. Quality of life, depression, anxiety and loneliness in patients with bullous pemphigoid. A case control study. An Bras Dermatol. 2016 Sep-Oct;91(5):601-603.
- Hammers CM, Stanley JR. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid. Annu Rev Pathol. 2016 May 23;11:175-97.
- Yan L, Wang JM, Zeng K. Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis. Br J Dermatol. 2012 Oct;167(4):768-77.
- Moro F, Sinagra JLM, Salemme A, Fania L, Mariotti F, Pira A, Didona B, Di Zenzo G. Pemphigus: trigger and predisposing factors. Front Med (Lausanne). 2023 Dec 27;10:1326359.
- Moro F, Fania L, Sinagra JLM, Salemme A, Di Zenzo G. Bullous Pemphigoid: Trigger and Predisposing Factors. Biomolecules. 2020 Oct 10;10(10):1432.
- Shipman AR, Reddy H, Wojnarowska F. Association between the subepidermal autoimmune blistering diseases linear IgA disease and the pemphigoid group and inflammatory bowel disease: two case reports and literature review. Clin Exp Dermatol. 2012 Jul;37(5):461-8.
- Yoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI. Gut Microbiota and Immune System Interactions. Microorganisms. 2020 Oct 15;8(10):1587.
- Huttenhower C, Kostic AD, Xavier RJ. Inflammatory bowel disease as a model for translating the microbiome. Immunity. 2014 Jun 19;40(6):843-54.
- Edwards CJ, Costenbader KH. Epigenetics and the microbiome: developing areas in the understanding of the aetiology of lupus. Lupus. 2014 May;23(6):505-6.
- van der Houwen TB, van Laar JAM, Kappen JH et al. Behçet’s Disease Under Microbiotic Surveillance? A Combined Analysis of Two Cohorts of Behçet’s Disease Patients. Front Immunol. 2020 Jun 12;11:1192.
- De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut-Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions. Microorganisms. 2021 Feb 11;9(2):353.
- Buhaș MC, Gavrilaș LI, Candrea R et al. Gut Microbiota in Psoriasis. Nutrients. 2022 Jul 20;14(14):2970.
- Manos J. The human microbiome in disease and pathology. APMIS. 2022 Dec;130(12):690-705
- Rinninella E, Raoul P, Cintoni M et al. What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms. 2019 Jan 10;7(1):14.
- Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res (2020) 30(6):492–506.
- Mousa WK, Chehadeh F, Husband S. Microbial dysbiosis in the gut drives systemic autoimmune diseases. Front Immunol. 2022 Oct 20;13:906258.
- Petta I, Fraussen J, Somers V, Kleinewietfeld M. Interrelation of Diet, Gut Microbiome, and Autoantibody Production. Front Immunol. 2018 Mar 6;9:439.
- Szymula A, Rosenthal J, Szczerba BM, Bagavant H, Fu SM, Deshmukh US. T cell epitope mimicry between Sjögren’s syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol. 2014 May-Jun;152(1-2):1-9.
- Rashid T, Ebringer A. Autoimmunity in Rheumatic Diseases Is Induced by Microbial Infections via Crossreactivity or Molecular Mimicry. Autoimmune Dis. 2012;2012:539282.
- O’Neill CA, Monteleone G, McLaughlin JT, Paus R. The gut-skin axis in health and disease: A paradigm with therapeutic implications. Bioessays. 2016 Nov;38(11):1167-1176.
- Ramírez-Boscá A, Navarro-López V, Martínez-Andrés A et al. Identification of Bacterial DNA in the Peripheral Blood of Patients With Active Psoriasis. JAMA Dermatol. 2015 Jun;151(6):6701.
- Fang H, Li Q, Wang G. The role of T cells in pemphigus vulgaris and bullous pemphigoid. Autoimmun Rev. 2020 Nov;19(11):102661.
- Shah AA, Sinha AA. Oxidative stress and autoimmune skin disease. Eur J Dermatol. 2013 Jan-Feb;23(1):5-13.
- Mitra S, De Sarkar S, Pradhan A et al. Levels of oxidative damage and proinflammatory cytokines are enhanced in patients with active vitiligo. Free Radic Res. 2017 Dec;51(11-12):986-994.
- Ni Q, Zhang P, Li Q, Han Z. Oxidative Stress and Gut Microbiome in Inflammatory Skin Diseases. Front Cell Dev Biol. 2022 Mar 7;10:849985.
- Liu X, van Beek N, Cepic A et al. The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibility. Front Immunol. 2023 Nov 10;14:1212551.
- Guo Z, Yiu N, Hu Z et al. Alterations of fecal microbiome and metabolome in pemphigus patients. J Autoimmun. 2023 Dec;141:103108.
- De Filippis F, Pasolli E, Ercolini D. Newly Explored Faecalibacterium Diversity Is Connected to Age, Lifestyle, Geography, and Disease. Curr Biol. 2020 Dec 21;30(24):4932-4943.e4.
- Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 2017 Apr;11(4):841-852.
- Mahmud MR, Akter S, Tamanna SK et al. Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases. Gut Microbes. 2022 Jan-Dec;14(1):2096995.
- Sokol H, Pigneur B, Watterlot L et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6.
- Carlsson AH, Yakymenko O, Olivier I et al. Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scand J Gastroenterol. 2013 Oct;48(10):1136-44.
- Eppinga H, Sperna Weiland CJ, Thio Hb et al. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa. J Crohns Colitis. 2016 Sep;10(9):1067-75
- Thirion F, Guilly S, Fromentin S et al. Changes in Gut Microbiota of Patients with Atopic Dermatitis During Balneotherapy. Clin Cosmet Investig Dermatol. 2022 Feb 2;15:163-176.
- Huang S, Mao J, Zhou L, Xiong X, Deng Y. The imbalance of gut microbiota and its correlation with plasma inflammatory cytokines in pemphigus vulgaris patients. Scand J Immunol. 2019 Sep;90(3):e12799.
- Low L, Suleiman K, Shamdas M et al. Gut Dysbiosis in Ocular Mucous Membrane Pemphigoid. Front Cell Infect Microbiol. 2022 Apr 14;12:780354.
- Hu X, Wu Q, Fan Y et al. Identification of gut microbiota dysbiosis in bullous pemphigoid under different disease activity. Exp Dermatol. 2023 Dec;32(12):2149-2159.
- Liu R, Peng C, Jing D et al. Lachnospira is a signature of antihistamine efficacy in chronic spontaneous urticaria. Exp Dermatol. 2022 Feb;31(2):242-247.
- Nylund L, Nermes M, Isolauri E, Salminen S, de Vos WM, Satokari R. Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy. 2015 Feb;70(2):241-4.
- Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. The Controversial Role of Human Gut Lachnospiraceae. Microorganisms. 2020 Apr 15;8(4):573.
- Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008 May 13;585(2-3):325-37
- Wang Y, Xia X, Zhou X et al. Association of gut microbiome and metabolites with onset and treatment response of patients with pemphigus vulgaris. Front Immunol. 2023 Apr 14;14:1114586.
- Litvak Y, Byndloss MX, Tsolis RM, Bäumler AJ. Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction. Curr Opin Microbiol. 2017 Oct;39:1-6.
- Mu Q, Kirby J, Reilly CM, Luo XM. Leaky Gut as a Danger Signal for Autoimmune Diseases. Front Immunol. 2017 May 23;8:598.
- Chalmers JR, Wojnarowska F, Kirtschig G et al. A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/ day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial. Health Technol Assess. 2017 Mar;21(10):1-90.
- Mason JM, Chalmers JR, Godec T et al. U.K. Dermatology Clinical Trials Network BLISTER Study Group. Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial. Br J Dermatol. 2018 Feb;178(2):415-423.
- Han Z, Fan Y, Wu Q et al. Comparison of gut microbiota dysbiosis between pemphigus vulgaris and bullous pemphigoid. Int Immunopharmacol. 2024 Feb 15;128:111470.
- Nagpal R, Wang S, Ahmadi S et al. Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome. Sci Rep. 2018 Aug 23;8(1):12649
- Groeger D, O’Mahony L, Murphy EF et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes. 2013 Jul-Aug;4(4):325-39
- Buhaș MC, Candrea R, Gavrilaș LI et al. Transforming Psoriasis Care: Probiotics and Prebiotics as Novel Therapeutic Approaches. Int J Mol Sci. 2023 Jul 7;24(13):11225.
- Umborowati MA, Damayanti D, Anggraeni S et al. The role of probiotics in the treatment of adult atopic dermatitis: a meta-analysis of randomized controlled trials. J Health Popul Nutr. 2022 Aug 17;41(1):37.
- Cesaroni I, Poteca H, Garrido A. The use of probiotic solution as supplement and restoring agent in some skin pathologies: Pemphigoid lesions, psoriasis, ulcerations and others. Proceedings of the Nutrition Society. 2013;72(OCE1):E23.
- Rungjang A, Meephansan J, Bing Thio H. Skin and gut microbiota in psoriasis: a systematic review. Hum Microbiome. 2021.
- Kim JH, Kim K, Kim W. Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy. Exp Mol Med. 2021;53(5):907–916.
- Emtenani S, Hertl M, Schmidt E, Hudemann C. Mouse models of pemphigus: valuable tools to investigate pathomechanisms and novel therapeutic interventions. Front Immunol. 2023 Apr 27;14:1169947.
- Pollmann R, Eming R. Research Techniques Made Simple: Mouse Models of Autoimmune Blistering Diseases. J Invest Dermatol. 2017 Jan;137(1):e1-e6.